JP2005511556A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005511556A5 JP2005511556A5 JP2003539665A JP2003539665A JP2005511556A5 JP 2005511556 A5 JP2005511556 A5 JP 2005511556A5 JP 2003539665 A JP2003539665 A JP 2003539665A JP 2003539665 A JP2003539665 A JP 2003539665A JP 2005511556 A5 JP2005511556 A5 JP 2005511556A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- group
- compound
- use according
- following formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 52
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 35
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 30
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 19
- 150000001408 amides Chemical class 0.000 claims 17
- 150000002148 esters Chemical class 0.000 claims 17
- 150000003839 salts Chemical class 0.000 claims 15
- 239000012453 solvate Substances 0.000 claims 15
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 12
- 125000004093 cyano group Chemical group *C#N 0.000 claims 8
- 125000006681 (C2-C10) alkylene group Chemical group 0.000 claims 7
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 6
- -1 -NMe 2 Chemical group 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 4
- 210000002997 osteoclast Anatomy 0.000 claims 4
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 claims 2
- 208000006386 Bone Resorption Diseases 0.000 claims 2
- 125000004423 acyloxy group Chemical group 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000005257 alkyl acyl group Chemical group 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 125000004103 aminoalkyl group Chemical group 0.000 claims 2
- 125000005251 aryl acyl group Chemical group 0.000 claims 2
- 125000006267 biphenyl group Chemical group 0.000 claims 2
- 230000024279 bone resorption Effects 0.000 claims 2
- 125000005488 carboaryl group Chemical group 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 125000004181 carboxyalkyl group Chemical group 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000001033 ether group Chemical group 0.000 claims 2
- 150000002170 ethers Chemical class 0.000 claims 2
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 claims 2
- 125000001188 haloalkyl group Chemical group 0.000 claims 2
- 125000003106 haloaryl group Chemical group 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 2
- 125000005647 linker group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 208000020084 Bone disease Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 208000016738 bone Paget disease Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 210000000987 immune system Anatomy 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 230000004083 survival effect Effects 0.000 claims 1
- BWXJBIKZQOXOMW-UHFFFAOYSA-N CC(C)Cc1ccc(C(C)C(OCCCCCCO)=O)cc1 Chemical compound CC(C)Cc1ccc(C(C)C(OCCCCCCO)=O)cc1 BWXJBIKZQOXOMW-UHFFFAOYSA-N 0.000 description 1
- NKRVCNXCSOFNEL-UHFFFAOYSA-N CC(C)Cc1ccc(C(C)C(OCCCCCO)=O)cc1 Chemical compound CC(C)Cc1ccc(C(C)C(OCCCCCO)=O)cc1 NKRVCNXCSOFNEL-UHFFFAOYSA-N 0.000 description 1
- LHOOMJCOKSYNPL-UHFFFAOYSA-N CC(C)Cc1ccc(C(C)C(OCCCCO)=O)cc1 Chemical compound CC(C)Cc1ccc(C(C)C(OCCCCO)=O)cc1 LHOOMJCOKSYNPL-UHFFFAOYSA-N 0.000 description 1
- CTRHGMPYFSAMOZ-UHFFFAOYSA-N CC(C)Cc1ccc(C(C)C(OCCCO)=O)cc1 Chemical compound CC(C)Cc1ccc(C(C)C(OCCCO)=O)cc1 CTRHGMPYFSAMOZ-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0126157.7A GB0126157D0 (en) | 2001-10-31 | 2001-10-31 | Therapeutic compounds |
| GB0126157.7 | 2001-10-31 | ||
| PCT/GB2002/004933 WO2003037321A1 (en) | 2001-10-31 | 2002-10-31 | Alkane diol derivatives as therapeutic agents for the treatment of bone conditions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005511556A JP2005511556A (ja) | 2005-04-28 |
| JP2005511556A6 JP2005511556A6 (ja) | 2005-08-04 |
| JP2005511556A5 true JP2005511556A5 (enExample) | 2006-01-05 |
Family
ID=9924891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003539665A Pending JP2005511556A (ja) | 2001-10-31 | 2002-10-31 | 骨疾患の処置のための治療薬としてのアルカンジオール誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7745424B2 (enExample) |
| EP (1) | EP1441716B1 (enExample) |
| JP (1) | JP2005511556A (enExample) |
| KR (1) | KR20050042044A (enExample) |
| AT (1) | ATE327748T1 (enExample) |
| CA (1) | CA2465399A1 (enExample) |
| DE (1) | DE60211935T2 (enExample) |
| GB (1) | GB0126157D0 (enExample) |
| WO (1) | WO2003037321A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060286064A1 (en) * | 2000-08-30 | 2006-12-21 | Medivas, Llc | Therapeutic polymers and methods |
| US20060177416A1 (en) | 2003-10-14 | 2006-08-10 | Medivas, Llc | Polymer particle delivery compositions and methods of use |
| US7572825B2 (en) | 2003-05-07 | 2009-08-11 | The University Court Of The University Of Aberdeen | Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| US20060188469A1 (en) * | 2003-10-14 | 2006-08-24 | Medivas, Llc | Vaccine delivery compositions and methods of use |
| US7589228B2 (en) | 2004-05-28 | 2009-09-15 | Nippon Shokubai Co., Ltd. | Fluorine-containing compound |
| GB0412553D0 (en) | 2004-06-04 | 2004-07-07 | Univ Aberdeen | Therapeutic agents for the treatment of bone conditions |
| US20070053984A1 (en) * | 2005-03-03 | 2007-03-08 | Monique Spann-Wade | Topical gels compositions |
| JP5178520B2 (ja) | 2005-09-22 | 2013-04-10 | メディバス エルエルシー | 固体ポリマー送達組成物およびその使用法 |
| JP5192384B2 (ja) | 2005-09-22 | 2013-05-08 | メディバス エルエルシー | ビス−（α−アミノ）−ジオール−ジエステル含有ポリ（エステルアミド）およびポリ（エステルウレタン）組成物および使用の方法 |
| US20080317684A1 (en) * | 2006-09-06 | 2008-12-25 | Isw Group, Inc. | Topical Compositions |
| GB0705400D0 (en) * | 2007-03-21 | 2007-05-02 | Univ Aberdeen | Therapeutic compounds andm their use |
| GB0817207D0 (en) | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | therapeutic apsac compounds and their use |
| GB0817208D0 (en) | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | Therapeutic apsap compounds and their use |
| US20110250297A1 (en) * | 2008-09-25 | 2011-10-13 | Oronsky Bryan T | Treatment of Hyperproliferative Disorders Using Cardiac Glycosides |
| US9873765B2 (en) | 2011-06-23 | 2018-01-23 | Dsm Ip Assets, B.V. | Biodegradable polyesteramide copolymers for drug delivery |
| US9963549B2 (en) | 2011-06-23 | 2018-05-08 | Dsm Ip Assets, B.V. | Biodegradable polyesteramide copolymers for drug delivery |
| CN103003228B (zh) * | 2011-07-21 | 2015-03-25 | 侯文阁 | 一种基于布洛芬的化合物及其制备方法和应用及药物制剂 |
| US11964956B2 (en) | 2012-09-06 | 2024-04-23 | Northeastern University | Cannabinergic compounds and uses thereof |
| WO2014039042A1 (en) | 2012-09-06 | 2014-03-13 | Northeastern University | Novel cannabinergic compounds and uses thereof |
| WO2014134127A1 (en) * | 2013-02-26 | 2014-09-04 | Northeastern University | Cannabinergic nitrate esters and related analogs |
| EP2818531B1 (en) * | 2013-06-25 | 2017-07-26 | Merck Patent GmbH | Polymerisable compounds and the use thereof in liquid-crystal displays |
| GB201311361D0 (en) | 2013-06-26 | 2013-08-14 | Pimco 2664 Ltd | Compounds and their therapeutic use |
| ES2899852T3 (es) | 2014-12-17 | 2022-03-15 | Pimco 2664 Ltd | Compuestos de N-(4-hidroxi-4-metil-ciclohexil)-4-fenil-bencenosulfonamida y N-(-4-hidroxi-4-metil-ciclohexil)-4-(2-piridil)-bencenosulfonamida y su uso terapéutico |
| WO2016097297A1 (en) | 2014-12-18 | 2016-06-23 | Dsm Ip Assets B.V. | Drug delivery system for delivery of acid sensitive drugs |
| CN113402386B (zh) * | 2021-05-28 | 2024-05-03 | 武汉亿科德精细化工有限公司 | 一种新戊二醇二苯甲酸酯的合成方法 |
| WO2024083934A1 (en) | 2022-10-19 | 2024-04-25 | Basf Se | Method for preparing 1,4-butanediol diesters |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB663072A (en) | 1947-05-24 | 1951-12-19 | British Celanese | Improvements relating to compositions comprising organic thermoplastic substances |
| GB661185A (en) | 1947-11-24 | 1951-11-21 | Sterling Drug Inc | Improvements in or relating to the production of alkoxyalkyl esters of iodobenzoic acids |
| GB716877A (en) | 1951-07-25 | 1954-10-13 | British Celanese | Improvements in polyesters and their intermediates |
| GB774180A (en) | 1953-11-18 | 1957-05-08 | Cecil Reginald Burch | Grading or separation of solid materials in liquid suspension |
| GB774635A (en) | 1954-06-29 | 1957-05-15 | Thomae Gmbh Dr K | New benzoic acid derivatives, and processes for their preparation |
| JPS4326316Y1 (enExample) | 1964-11-21 | 1968-11-01 | ||
| CH496647A (de) | 1967-12-15 | 1970-09-30 | Hoechst Ag | Verfahren zur Herstellung von Terephthalsäure-(B-hydroxy-äthyl)-estern |
| US3689535A (en) | 1968-09-26 | 1972-09-05 | John Kollar | Process for preparing ethylene glycol esters |
| US3715389A (en) | 1971-03-01 | 1973-02-06 | Halcon International Inc | Process for preparing glycol esters from olefinically unsaturated compounds |
| DE2602030C2 (de) | 1976-01-21 | 1983-12-01 | Henkel KGaA, 4000 Düsseldorf | Diphosphonoalkancarbonsäuren und Verfahren zu deren Herstellung |
| JP2748005B2 (ja) | 1988-10-13 | 1998-05-06 | 旭電化工業株式会社 | 光学活性ビフェニル化合物および該化合物含有液晶組成物 |
| IT1256450B (it) | 1992-11-26 | 1995-12-05 | Soldato Piero Del | Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione |
| US5374707A (en) * | 1993-02-18 | 1994-12-20 | Monsanto Company | Hydroxy ethyl bibenzoate |
| JP3538444B2 (ja) * | 1993-09-30 | 2004-06-14 | 株式会社三光開発科学研究所 | ジヒドロキシ化合物およびその製造方法 |
| US6124474A (en) | 1999-12-21 | 2000-09-26 | Abbott Laboratories | Synthesis of chiral 2-azetidinemethanol compounds |
| JP4326316B2 (ja) | 2003-12-09 | 2009-09-02 | 日産自動車株式会社 | 車両のトラクションコントロール装置 |
-
2001
- 2001-10-31 GB GBGB0126157.7A patent/GB0126157D0/en not_active Ceased
-
2002
- 2002-10-31 AT AT02777456T patent/ATE327748T1/de not_active IP Right Cessation
- 2002-10-31 WO PCT/GB2002/004933 patent/WO2003037321A1/en not_active Ceased
- 2002-10-31 CA CA002465399A patent/CA2465399A1/en not_active Abandoned
- 2002-10-31 EP EP02777456A patent/EP1441716B1/en not_active Expired - Lifetime
- 2002-10-31 KR KR1020047006591A patent/KR20050042044A/ko not_active Withdrawn
- 2002-10-31 US US10/494,327 patent/US7745424B2/en not_active Expired - Lifetime
- 2002-10-31 JP JP2003539665A patent/JP2005511556A/ja active Pending
- 2002-10-31 DE DE60211935T patent/DE60211935T2/de not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005511556A5 (enExample) | ||
| JP2004511462A5 (enExample) | ||
| DK1177176T3 (da) | Triarylsyrederivater som PPAR-receptorligander | |
| EP1797878A3 (en) | Benzothiazole derivatives | |
| JP2020507589A5 (enExample) | ||
| JP2005504749A5 (enExample) | ||
| PL393711A1 (pl) | Sucha kompozycja, dawka jednostkowa, roztwór, sposób przygotowania roztworu do oczyszczania okrężnicy, zestaw i kompozycja oraz sposób oczyszczania okrężnicy ssaka | |
| JP2007503202A5 (enExample) | ||
| BR0207871A (pt) | Composição para liberar bisfosfonato para um alvo | |
| JP2002518502A5 (enExample) | ||
| JP2007522220A5 (enExample) | ||
| JP2008533191A5 (enExample) | ||
| EP2322513A3 (en) | Intermediates | |
| ATE266013T1 (de) | 1-phenyl-4-benzylpiperazine: spezifische liganden für den dopamin rezeptor (d4) | |
| JP2005530811A5 (enExample) | ||
| JP2008505157A5 (enExample) | ||
| EP2042490A3 (en) | Benzimidazole derivatives as vanilloid receptor antagonists | |
| RU99127433A (ru) | Эрголиновые производные и их применение в качестве антагонистов рецепторов соматостатина | |
| JP2002525323A5 (enExample) | ||
| JP2018530582A5 (enExample) | ||
| JP2005526773A5 (enExample) | ||
| EP2298751A3 (en) | Polymorphs of ritonavir | |
| EP1681290A3 (en) | Imidazole derivatives, production method thereof and use thereof | |
| RU2004105144A (ru) | Комбинации, включающие эпотилоны, и их фармацевтическое применение | |
| JP2008520662A5 (enExample) |